Concepedia

Jeffrey B. Hargis

JB

12

Publications

1.4K

Citations

12

H-Index

1994

Active since

Affiliations

Kentuckiana Pulmonary Associates(Current)

Walter Reed Army Institute of Research

Norton Healthcare

University of Louisville

Jeffrey B. Hargis is an author at Kentuckiana Pulmonary Associates specializing in oncology, medicine, and health sciences.

Top concepts

MedicineOncologyHealthCancer TherapyRadiation OncologyCancer ResearchClinical TrialsGliomaSurgeryPathology

Publications per year

1994–2022

12

Publications

12

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.

Gary L. Rosner, Jeffrey B. Hargis, Donna Hollis et al. · Journal of Clinical Oncology · 1996 · 181 citations

Opportunistic pulmonary infections with fludarabine in previously treated patients with low‐grade lymphoid malignancies: A role for pneumocystis carinii pneumonia prophylaxis

John C. Byrd, Jeffrey B. Hargis, Kent E. Kester et al. · American Journal of Hematology · 1995 · 111 citations

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.

A. A. Miller, Jeffrey B. Hargis, Rogério Lilenbaum et al. · Journal of Clinical Oncology · 1994 · 83 citations

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study.

Rogério Lilenbaum, Mark J. Ratain, A. A. Miller et al. · Journal of Clinical Oncology · 1995 · 64 citations

Rows per page

1–5 of 12